GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $393,000 | -0.3% | 9,035 | 0.0% | 0.02% | +29.4% |
Q1 2022 | $394,000 | -1.0% | 9,035 | 0.0% | 0.02% | +13.3% |
Q4 2021 | $398,000 | +15.4% | 9,035 | 0.0% | 0.02% | +15.4% |
Q3 2021 | $345,000 | -4.2% | 9,035 | 0.0% | 0.01% | -7.1% |
Q2 2021 | $360,000 | +11.8% | 9,035 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $322,000 | -20.7% | 9,035 | -18.0% | 0.01% | -22.2% |
Q4 2020 | $406,000 | -2.2% | 11,021 | 0.0% | 0.02% | -14.3% |
Q3 2020 | $415,000 | -7.8% | 11,021 | 0.0% | 0.02% | -19.2% |
Q2 2020 | $450,000 | +7.7% | 11,021 | 0.0% | 0.03% | -23.5% |
Q1 2020 | $418,000 | -19.3% | 11,021 | 0.0% | 0.03% | +6.2% |
Q4 2019 | $518,000 | +10.2% | 11,021 | 0.0% | 0.03% | +3.2% |
Q3 2019 | $470,000 | +6.6% | 11,021 | 0.0% | 0.03% | +10.7% |
Q2 2019 | $441,000 | +63.3% | 11,021 | +70.4% | 0.03% | +55.6% |
Q1 2019 | $270,000 | – | 6,469 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |